期刊文献+

rhKD/APP对肾脏缺血再灌注损伤大鼠的肾保护作用 被引量:3

The protection of rhKD/APP against renal ischemia-reperfusion injury in rats
下载PDF
导出
摘要 目的观察对大鼠肾缺血再灌注损伤的保护和治疗。方法取wistar大鼠60只,根据给药不同随机分为6组,伪手术组,模型组,小、中、大剂量组、对照组。造模24小时后检测血清肌酐(Cr)、尿素氮(BUN)、尿NAG,并光镜、电镜观察肾脏组织病理变化。结果各实验组与伪手术组比较Cr、BUN、NAG明显升高(P<0.05),与模型组比较rhKD/APP中、大剂量组、对照组Cr、BUN、NAG明显降低(P<0.01 orP<0.05),小剂量组无明显差异。光镜电镜观察rhKD/APP中、大剂量组、对照组细胞损害较模型组明显减轻。结论rhKD/APP对大鼠肾缺血再灌注损伤确实具有器官保护作用。 Objective to observe the protection and treatment of rhKD/APP against renal isehemia-repeffusion injury in rats. Methods 60 Wistar Rats, were randomly divided into six groups according to the drugs given to the rats: sham-operation group, model group,low,middle and high doses rhKD/APP groups and contrast group, creatinine(Cr) in serum, bloed urea nitrogen(BUN) and NAG in urine were tested after 24-hour of making model, and pathological changes in renal tissues were observed under light microscope and electron microscope. Results Comparing with sham-operation group, Cr, BUN and NAG in other groups increased significantly( P 〈 0.05). Comparing with model group, Cr, BUN and NAG in middle-dose rhKD/APP group, high- dose rhKD/APP group and contrast group decreased significantly, there was no distinct difference between model group and low-dose rhKD/APP group( P 〈 0.01 or P 〈 0.05). Cell destoryment was significantly relieved in middle-dose rhKD/APP group,high-dose rhKD/APP group and contrast group comparing with model group observed by light microscope and electron microscope. Conclusion rhKD/APp has organic protective effect on renal isehemia-reperfusion injury in rats.
出处 《中国实验诊断学》 2008年第9期1105-1108,共4页 Chinese Journal of Laboratory Diagnosis
关键词 缺血再灌注损伤 RHKD/APP 蛋白酶抑制剂 肾损伤 isehemia repeffusion injury rhKD/APP aprotinin renal damage
  • 相关文献

参考文献6

二级参考文献25

  • 1王虹蛟,张馨木,常淑芳,贺巾超,杨丽丽,孙波.抑肽酶对小鼠急性肝损伤的保护作用[J].中国实验诊断学,2005,9(3):420-421. 被引量:11
  • 2贺巾超,杨莉莉,马杰,颜波群,韩树海,侯立中,颜炜群.rhKPI/AβPP大规模发酵及纯化工艺[J].吉林大学学报(医学版),2006,32(2):278-281. 被引量:10
  • 3Ashraf S, Tian Y, Coman D, et al."Low-dose"aprotinin modifies hemostasis but not proinflammatory cytokine release. Ann Thorac Surg,1997,63 : 68-73.
  • 4Gurevitch J, Barak J, Hochhauser E, et al. Aprotinin improves myocardial recovery after ischemia and reperfiasion. Effects of the drug on isolated rat hearts. J Thorac Cardiovasc Surg, 1994,108:109-118.
  • 5Bull DA, Connors RC, Albanil A, el at. Aprotinin preserves myocardial biochemical function during cold storage through suppression of tumor necrosis factor. J Thorac Cardiovasc Surg,2000, 119:242-250.
  • 6Grocott HP, Sheng H, Miura Y, et al. The effects of aprotinin on outcome from cerebral ischemia in the rat. Anesth Analg, 1999,88:1-7.
  • 7Mathias MA, Tribble CG, Dietz JF, el at. Aprotinin improves pulmonary function during reperfuslon in an isolated lung model. Ann Thorac Surg,2000, 70:1671-1674.
  • 8Porte R.I, Molenaar IQ, Begliiominl B, el at. Aprotinin reduces red blood and transfusion requirements in orthotopic liver transplantation : a multicenter randomized double-blind study. Lancet, 2000,355 : 1303-1309.
  • 9Molennaar IQ, Begliomini B, Grazi GL, et al. The effect of approtinin on renal function in orthotopic liver transplantation. Transplantation,2001, 71:247-252.
  • 10Madhala-Givon O, Hochhauser E, Weinbroum A, el at. The influence of apmtinin on myocardial function after liver ischemia-reperfusion. Isr Med Assoc J,2000,2:450-454.

共引文献26

同被引文献39

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部